Facebook
X
LinkedIn
Forward
Infectious Disease Clinical Bootcamp for APPs (Part 2)
Audio/Video content recorded at IDWeekTM 2025 in Atlanta, GA. Content and presentation format may vary by session.
IDSA’s Infectious Disease Clinical Bootcamp, Part 2, is an advanced, practice-focused course designed for APPs ready to deepen their clinical expertise. It contains updated guidance on pediatric antibiotic duration, recognition of Kawasaki disease, and critical insights from major clinical trials shaping current practice. Faculty will also explore the evolving role of dual beta-lactam regimens and novel beta-lactam/beta-lactamase inhibitor combinations, key considerations in infection risk and prophylaxis for immunosuppressed patients, and practical approaches to evaluating and managing complex fungal, bacterial, and viral infections. The course also includes in-depth look at diagnostic stewardship and effective implementation strategies to optimize test utilization and enhance patient care.
Target Audience
- Nurse Practitioners (NPs)
- Physician Assistants (PAs)
- Clinical Nurse Specialists (CNSs)
- Others in APP roles interested in ID Topics
Learning Objectives
At the conclusion of this course, participants will be able to:
- describe new age parameters for prescribing antibiotic duration for at least 3 common pediatric illnesses;
- identify the classic kawasaki disease patient;
- describe the clinical implications of recent major clinical trials that are shaping current infectious disease practices;
- discuss the place in therapy for dual beta-lactam regimens and novel beta-lactam/beta-lactamase inhibitor combinations, incorporating pathogen resistance mechanisms and pharmacokinetic/pharmacodynamic principles;
- classify the varied risks of infection in immunosuppressed patients and common approaches to prophylaxis;
- examine patients with fungal, bacterial, and viral infections and devise a treatment plan;
- explain diagnostic stewardship and evaluate its impact on minimizing medical overuse and enhancing diagnostic accuracy;
- identify strategies for the effective implementation of diagnostic tests to optimize patient care.
All relevant financial relationships have been mitigated.
Workshop Moderator(s)
Leah Yoke, PA-C, MCHS
Physician Assistant
University of Washington; Fred Hutch Cancer Research Center
Seattle, WA, United States
No financial relationships to disclose
Courtney Russ-Friedman, MSN, FNP-BC
Advanced Practice Provider
Wake Forest Baptist Health
Winston-Salem, NC, United States
No financial relationships to disclose
Faculty
Paul Pottinger, MD (he/him/his)
Professor of Medicine
Infectious Diseases
University of Washington School of Medicine
Seattle, WA, United States
No financial relationships to disclose.
Christopher Ohl, MD
Professor of Medicine
Wake Forest School of Medicine
Winston Salem, NC, United States
No financial relationships to disclose.
Denise McCulloch, MD, MPH
Assistant Professor
Fred Hutchinson Cancer Center
Seattle, WA, United States
Pfizer, Inc.: Grant/Research Support
Daniel Morgan, MD, MS
Professor
Epidemiology & Public Health
University of Maryland School of Medicine
Baltimore, MD, United States
No financial relationships to disclose.
John Williamson, PharmD (he/him/his)
Associate Professor, Infectious Diseases
Wake Forest School of Medicine
Winston-Salem, NC, United States
F2G Ltd: Grant/Research Support; Locus Biosciences: Grant/Research Support; ST Pharm: Grant/Research Support
Tresa Zielinski, DNP, RN, APRN-NP, CPNP-PC (she/her/hers)
Pediatric Nurse Practitioner
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, IL, United States
No financial relationships to disclose.
Accreditation Statement
In support of improving patient care, IDSA is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME Credit Designation Statement
IDSA designates this enduring material for a maximum of 4 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Physician participation information will be shared with ABIM through ACCME PARS.
Available Credit
- 4.00 ABIM MOC II
- 4.00 ACPE Pharmacy
- 4.00 AMA PRA Category 1 Credit(s)™